Amrutanjan Health Care Ltd has informed BSE that the Board of Directors of the Company at its meeting held on August 11, 2016, inter alia, had: - Approved the scheme of merger of M/s. Amrutanjan Pharmaessense Private Limited, the wholly owned subsidiary, with M/s. Amrutanjan Health Care Limited. The Board Meeting commenced at 11.15 A.M. and concluded at 3.30 P.M. Amrutanjan Health Care Ltd has informed BSE that the Board of Directors of the Company at its meeting held on February 09, 2017, had inter-alia: 1.Approved the modified / altered Scheme of merger of the Wholly Owned Subsidiary, M/s. Amrutanjan Pharmaessense Private Limited with M/s. Amrutanjan Health Care Limited. (As per BSE Announcement dated on 09.02.2017) Amrutanjan Health Care Ltd has informed BSE that the Board of Directors of the Company at its meeting held on February 09, 2017 had inter-alia approved the modified/ altered Scheme of Merger of the Wholly Owned Subsidiary, M/s. Amrutanjan Pharmaessense Private Limited with the Parent Company, M/s. Amrutanjan Health Care Limited. (As per BSE Announcement dated on 17.02.2017) We hereby inform that the Scheme of Amalgamation of M/s. Amrutanjan Pharmaessense Private Limited (Transferor) with M/s. Amrutanjan Health Care Limited (Transferee)was approved by the National Company Law Tribunal (NCLT) , Chennai vide their order dated July 13, 2017. e- form INC-28 has been filed with the Registrar of Companies on July 19, 2017 (SRN no.- G48623755) in pursuant to the above order (As Per BSE Announcement Dated On 20/07/2017)